These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 19372795)

  • 21. Suppression of HIV replication in the resting CD4+ T cell reservoir by autologous CD8+ T cells: implications for the development of therapeutic strategies.
    Chun TW; Justement JS; Moir S; Hallahan CW; Ehler LA; Liu S; McLaughlin M; Dybul M; Mican JM; Fauci AS
    Proc Natl Acad Sci U S A; 2001 Jan; 98(1):253-8. PubMed ID: 11136258
    [TBL] [Abstract][Full Text] [Related]  

  • 22. TZA, a Sensitive Reporter Cell-based Assay to Accurately and Rapidly Quantify Inducible, Replication-competent Latent HIV-1 from Resting CD4
    Sanyal A; Rangachar VS; Gupta P
    Bio Protoc; 2019 May; 9(10):. PubMed ID: 31428662
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Regulatory T cells: the ultimate HIV reservoir?
    Rocco J; Mellors JW; Macatangay BJ
    J Virus Erad; 2018 Oct; 4(4):209-214. PubMed ID: 30515299
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quantifying residual HIV-1 replication in patients receiving combination antiretroviral therapy.
    Zhang L; Ramratnam B; Tenner-Racz K; He Y; Vesanen M; Lewin S; Talal A; Racz P; Perelson AS; Korber BT; Markowitz M; Ho DD
    N Engl J Med; 1999 May; 340(21):1605-13. PubMed ID: 10341272
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reservoirs of HIV-1 in vivo: implications for antiretroviral therapy.
    Saksena NK; Potter SJ
    AIDS Rev; 2003; 5(1):3-18. PubMed ID: 12875103
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Modeling Kick-Kill Strategies toward HIV Cure.
    Hernandez-Vargas EA
    Front Immunol; 2017; 8():995. PubMed ID: 28894444
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Human Immunodeficiency Virus Playing Hide-and-Seek: Understanding the T
    Leong YA; Atnerkar A; Yu D
    Front Immunol; 2017; 8():622. PubMed ID: 28620380
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel immunological strategies for HIV-1 eradication.
    Jülg B; Barouch DH
    J Virus Erad; 2015 Oct; 1(4):232-6. PubMed ID: 27482421
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reservoirs for HIV-1.
    Siliciano RF
    Curr Infect Dis Rep; 1999 Aug; 1(3):298-304. PubMed ID: 11095802
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Targeted Nanocarrier Delivery of RNA Therapeutics to Control HIV Infection.
    Agbosu EE; Ledger S; Kelleher AD; Wen J; Ahlenstiel CL
    Pharmaceutics; 2022 Jun; 14(7):. PubMed ID: 35890248
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Establishment and maintenance of HIV latency: model systems and opportunities for intervention.
    Marsden MD; Zack JA
    Future Virol; 2010 Jan; 5(1):97-109. PubMed ID: 21318097
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Potential Contribution of Caveolin 1 to HIV Latent Infection.
    Sahay B; Mergia A
    Pathogens; 2020 Oct; 9(11):. PubMed ID: 33121153
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Simulating within host human immunodeficiency virus 1 genome evolution in the persistent reservoir.
    Jones BR; Joy JB
    Virus Evol; 2020 Jul; 6(2):veaa089. PubMed ID: 34040795
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Latent reservoirs for HIV-1.
    Blankson J; Persaud D; Siliciano RF
    Curr Opin Infect Dis; 1999 Feb; 12(1):5-11. PubMed ID: 17035753
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The X awakens: multifactorial ramifications of sex-specific differences in HIV-1 infection.
    Hagen S; Altfeld M
    J Virus Erad; 2016 Apr; 2(2):78-81. PubMed ID: 27482439
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HIV LATENT RESERVOIR CURE STRATEGIES.
    Destache CJ
    Isci Notes; 2016; 2016():. PubMed ID: 32483556
    [No Abstract]   [Full Text] [Related]  

  • 37. Current challenges and recent advances in the search for a cure for HIV.
    Jones RB
    J Int AIDS Soc; 2019 Feb; 22(2):e25248. PubMed ID: 30734500
    [No Abstract]   [Full Text] [Related]  

  • 38. Publisher Correction: Evidence that CD32a does not mark the HIV-1 latent reservoir.
    Osuna CE; Lim SY; Kublin JL; Apps R; Chen E; Mota TM; Huang SH; Ren Y; Bachtel ND; Tsibris AM; Ackerman ME; Jones RB; Nixon DF; Whitney JB
    Nature; 2018 Nov; 563(7733):E33. PubMed ID: 30315222
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evidence that CD32a does not mark the HIV-1 latent reservoir.
    Osuna CE; Lim SY; Kublin JL; Apps R; Chen E; Mota TM; Huang SH; Ren Y; Bachtel ND; Tsibris AM; Ackerman ME; Jones RB; Nixon DF; Whitney JB
    Nature; 2018 Sep; 561(7723):E20-E28. PubMed ID: 30232424
    [No Abstract]   [Full Text] [Related]  

  • 40. Eradication of human immunodeficiency virus-1 reservoir in the brain microglia.
    Tang Y; Jiang G
    Neural Regen Res; 2023 Mar; 18(3):552-553. PubMed ID: 36018174
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.